Keyphrases
Insulin
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Asia-Pacific Region
100%
Type 2 Diabetic Patients
100%
Asia-Pacific
100%
Evidence-based Clinical Practice Guideline
100%
Basal Insulin
100%
Clinical Thresholds
100%
Clinical Practice Guidelines
50%
Patient Care
50%
Grading Method
50%
Nave
50%
Dose-ranging
50%
Group Members
50%
Internal-external
50%
Fasting Plasma Glucose
50%
External Review
50%
Reporting Item
50%
Evaluation Assessment
50%
Assessment Development
50%
Grading of Recommendations
50%
Certainty of Evidence
50%
Intervention Effect
50%
Overall Response Rate
50%
Adult Patients
50%
Over 75
50%
Practice Guidelines
50%
Maintenance Dose
50%
Gla-300
50%
Detemir
50%
Starting Dose
50%
Glargine
50%
Optimal Maintenance
50%
Degludec
50%
Internal Review
50%
Review Process
50%
Agreement Rate
50%
Evaluation Object
50%
Care Guidelines
50%
Threshold Setting
50%
Protamine
50%
Reporting Checklist
50%
Insulin Glargine
50%
Evidence Evaluation
50%
Medicine and Dentistry
Clinician
100%
Maturity Onset Diabetes of the Young
100%
Patient with Type 2 Diabetes
66%
Systematic Review
33%
Checklist
33%
Insulin Glargine
33%
Optimal Drug Dose
33%
Maintenance Drug Dose
33%
Isophane Insulin
33%
Nursing and Health Professions
Practice Guideline
100%
Non Insulin Dependent Diabetes Mellitus
100%
Clinician
42%
Patient with Type 2 Diabetes
28%
Systematic Review
14%
Checklist
14%
Isophane Insulin
14%
Insulin Glargine
14%
Optimal Drug Dose
14%
Maintenance Drug Dose
14%
Glucose Blood Level
14%